Abstract
We conducted a national human serologic study of a hantavirus detected in Madagascar rodents using a commercial kit and a new ELISA targeting the virus. Our results suggest a conservative estimate of 2.7% (46/1,680) IgG seroprevalence. A second single-district study using the new ELISA revealed a higher prevalence (7.2%; 10/139).
Original language | English |
---|---|
Pages (from-to) | 587-590 |
Number of pages | 4 |
Journal | Emerging Infectious Diseases |
Volume | 26 |
Issue number | 3 |
Early online date | 19 Feb 2020 |
DOIs | |
Publication status | Published - Mar 2020 |
Bibliographical note
We thank all colleagues from the Virology, Plague andEpidemiology Units of the Institut Pasteur de Madagascar
who aided with field and laboratory work. We thank
Corinne Jallet for help with some ELISA assays and Rasa
Petraityte-Burneikiene and Aurelija Zvirbliene for providing
antigen for additional analysis. We thank Reagena for
constructive exchanges during provision of the kits.
This work was supported by Wellcome Trust Fellowships
(no. 081705 and 095171 to S.T.) and Institut Pasteur de
Madagascar, and by PTR (Progamme Transversal de
Recherche) HANTAREV at Institut Pasteur, Paris.